0001214659-22-008950.txt : 20220718 0001214659-22-008950.hdr.sgml : 20220718 20220718163018 ACCESSION NUMBER: 0001214659-22-008950 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220715 FILED AS OF DATE: 20220718 DATE AS OF CHANGE: 20220718 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Neal James R CENTRAL INDEX KEY: 0001600865 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39801 FILM NUMBER: 221089487 MAIL ADDRESS: STREET 1: 2910 SEVENTH STREET CITY: BERKELEY STATE: CA ZIP: 94710 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: XOMA Corp CENTRAL INDEX KEY: 0000791908 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 522154066 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2200 POWELL STREET STREET 2: SUITE 310 CITY: EMERYVILLE STATE: CA ZIP: 94608 BUSINESS PHONE: 510-204-7239 MAIL ADDRESS: STREET 1: 2200 POWELL STREET STREET 2: SUITE 310 CITY: EMERYVILLE STATE: CA ZIP: 94608 FORMER COMPANY: FORMER CONFORMED NAME: XOMA LTD /DE/ DATE OF NAME CHANGE: 19990107 FORMER COMPANY: FORMER CONFORMED NAME: XOMA CORP /DE/ DATE OF NAME CHANGE: 19920703 4 1 marketforms-56649.xml PRIMARY DOCUMENT X0306 4 2022-07-15 0000791908 XOMA Corp XOMA 0001600865 Neal James R C/O XOMA CORPORATION 2200 POWELL STREET, SUITE 310 EMERYVILLE CA 94608 true true false false CEO Common Stock 2022-07-15 4 M false 25000 4.03 A 36822 D Common Stock 2022-07-15 4 S false 20883 29.5501 D 15939 D Common Stock 2022-07-15 4 S false 3212 31.1877 D 12727 D Common Stock 2022-07-15 4 S false 905 31.8610 D 11822 D Common Stock 5560 I By 401(k) Plan Depositary Shares - 8.375% B Cumulative Stock 8000 I By spouse 8.625% Series A Cumulative Perpetual Preferred Stock 8000 I By spouse Stock Option (Right to Buy) 4.03 2022-07-15 4 M false 25000 0 D 2027-02-10 Common Stock 25000 218056 D The sales reported on this Form 4 were effected pursuant to a trading plan adopted by the reporting person pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.25 to $30.04, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.53 to $31.52, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.53 to $32.00, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Shares subject to this option have fully vested as of February 10, 2020. /s/ James R. Neal 2022-07-18